Zobrazeno 1 - 10
of 2 371
pro vyhledávání: '"t1d"'
Autor:
T. L. Kuraeva, A. V. Karpushkina, E. A. Andrianova, I. M. Valkova, T. V. Yakovleva, A. O. Emelyanov, E. A. Sechko, Z. G. Bezrukova, E. B. Khramova, Y. V. Girsh, I. V. Gunbina, V. A. Peterkova
Publikováno v:
Сахарный диабет, Vol 27, Iss 5, Pp 401-410 (2024)
Despite significant progress in the treatment of T1DM in children, achieving target levels of carbohydrate metabolism in children remains one of the most difficult tasks. The influence of the psychosocial state of the family on the ability to achieve
Externí odkaz:
https://doaj.org/article/f87054a9f7d24ed29b4a946d508a3e8c
Autor:
Azharuddin Sajid Syed Khaja, Naif K. Binsaleh, Mirza Masroor Ali Beg, Fauzia Ashfaq, Mohammad Idreesh Khan, Malak Ghazi Almutairi, Husam Qanash, Mohd Saleem, Ibrahim Abdelmageed Mohamed Ginawi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Type-1 diabetes (T1D) is an autoimmune disorder characterized by impaired insulin release by islet β cells. It has been shown that proinflammatory cytokines released during the disease can exacerbate the condition, while anti-inflammatory c
Externí odkaz:
https://doaj.org/article/eae3b94d235c4920a16901490f8ed411
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 10, Iss 1, Pp 1-5 (2024)
Abstract Background Type 1 diabetes mellitus (T1D) is an autoimmune disease caused by destruction of pancreatic islet beta-cells. There is significant residual beta-cell function, measured through circulating C-peptide, present at the time of T1D dia
Externí odkaz:
https://doaj.org/article/3a06861a5be447ea8e9a6169ac82befb
Autor:
Yu Qian, Shu Chen, Yan Wang, Yuyue Zhang, Jie Zhang, Liying Jiang, Hao Dai, Min Shen, Yunqiang He, Hemin Jiang, Tao Yang, Qi Fu, Kuanfeng Xu
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Our previous genome‑wide association studies (GWAS) have suggested rs912304 in 14q12 as a suggestive risk variant for type 1 diabetes (T1D). However, the association between this risk region and T1D subgroups and related clinica
Externí odkaz:
https://doaj.org/article/a96de09342be44c0a629bc5019df9d6b
Publikováno v:
Journal of Education, Health and Sport, Vol 75 (2024)
Introduction and purpose Type 1 diabetes (T1D) is an autoimmune disease that results in the destruction of pancreatic β cells, which leads to insulin deficiency and hyperglycemia. One significant factor that may influence the development of type 1
Externí odkaz:
https://doaj.org/article/e8dab1210e4544389667fcfc61b084e0
Autor:
Cassandra Bazile, Magdy M. Abdel Malik, Courtney Ackeifi, Randy L. Anderson, Roy W. Beck, Marc Y. Donath, Sanjoy Dutta, Joseph A. Hedrick, Stephen R. Karpen, Thomas W. H. Kay, Thomas Marder, Marjana Marinac, Jennifer McVean, Robert Meyer, Jeremy Pettus, Teresa Quattrin, Ruud H. J. Verstegen, Joshua A. Vieth, Esther Latres
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing β-cells in the pancreas. This destruction leads to chronic hyperglycemia, necessitating lifelong insulin therapy to manage blood glucose levels. Typ
Externí odkaz:
https://doaj.org/article/3d839e45f08449c58283852ff8e122f0
Autor:
Weidong Xie, Haojie Jiang, Yao Chen, Zhaojie Yu, Yaoyu Song, Huanhao Zhang, Sen Li, Shaoliang Han, Naxin Liu
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
BackgroundPrevious studies have suggested an association between Type 1 diabetes (T1D) and autoimmune diseases (AIDs), but the causal relationship remains unclear. Therefore, this study utilizes publicly available Genome-Wide Association Studies (GWA
Externí odkaz:
https://doaj.org/article/2e2c6e010e0e40c59b3dc4454d06fb26
Autor:
Natalija Jonić, Ivan Koprivica, Stavroula G. Kyrkou, Vasileios-Panagiotis Bistas, Christos Chatzigiannis, Nataša Radulović, Ivan Pilipović, Andjelina Jovanović, Milan B. Jovanović, Mirjana Dimitrijević, Andreas G. Tzakos, Ivana Stojanović
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Type 1 diabetes (T1D) is an autoimmune disease with a strong chronic inflammatory component. One possible strategy for the treatment of T1D is to stimulate the regulatory arm of the immune response, i.e. to promote the function of tolerogenic dendrit
Externí odkaz:
https://doaj.org/article/11b51184e3184bd1b78ab93ef5a4d033
Autor:
J.A. García-Rodríguez, Guy Yaoyotzin Cortés S․, Roberto Carlos Diaz-Velazco, Alberto Gudiño-Ochoa, Antonio Navarrete-Guzmán
Publikováno v:
Results in Control and Optimization, Vol 16, Iss , Pp 100454- (2024)
Diabetes Mellitus (DM) is emerging as a global concern, affecting people from early ages to adulthood and positioning itself as one of the leading causes of mortality worldwide. The post-COVID-19 era has been characterized by notable progress in the
Externí odkaz:
https://doaj.org/article/0d1c3a0d903d4a7389cedfbd586dc24c
Publikováno v:
Diabetes Epidemiology and Management, Vol 17, Iss , Pp 100247- (2025)
Type 1 diabetes mellitus (T1D) is a chronic autoimmune disease characterized by the selective destruction of pancreatic insulin-producing beta cells, primarily mediated by CD4+ and CD8+ T cells. This review comprehensively examines the latest advance
Externí odkaz:
https://doaj.org/article/088a8330076145008199e17361204d3b